Contents

Antibody Screen Blood Test: Positive, Negative, Pregnancy

The antibody screen (indirect Coombs test) looks for red-cell antibodies before a transfusion or in pregnancy. What a positive vs negative result means, titers, and anti-D — clearly explained.

Published July 20, 202611 min readWritten by the Blood Analysis Team · Reviewed and verified by Julien Priour

The antibody screen — also called the red blood cell antibody screen or indirect Coombs test — is a safety test that looks for antibodies against red blood cells other than the ABO ones. It is not a test for a disease: it's a pre-transfusion test and a pregnancy test, performed using the indirect antiglobulin test (IAT). Its result is reported as negative or positive — and, when positive, the specific antibody is identified and titered, rather than given as a number. This guide explains what the antibody screen is for, how to read a result, and why it's inseparable from your Rh factor and anti-D (RhoGAM) prevention. It's part of our blood type hub.

Key takeaways

  • The antibody screen looks for "irregular" red-cell antibodies (outside ABO): anti-D, -c, -E, -K (Kell), -Fya (Duffy), -Jka (Kidd), and more.1
  • It uses the indirect antiglobulin test (IAT / indirect Coombs test), a cornerstone method of transfusion medicine.23
  • Two main uses: before a transfusion (compatibility, to prevent a hemolytic reaction) and during pregnancy (to detect alloimmunization, especially anti-D).45
  • A negative antibody screen = no irregular antibody detected: transfusion is simpler, and it's reassuring in pregnancy at that point in time.6
  • A positive antibody screen = an antibody is identified and titered → antigen-negative, crossmatch-compatible blood is selected for transfusion, and closer monitoring is arranged in pregnancy.14
  • A positive result is not a disease — it's safety information for transfusion and obstetrics. No fasting is needed.

What is the antibody screen?

The antibody screen is a blood test that looks in your plasma for antibodies directed against antigens on the surface of red blood cells. These are called irregular (or atypical) antibodies because, unlike the ABO antibodies (anti-A, anti-B) that everyone with type O or A or B carries naturally from infancy, irregular antibodies appear only after exposure to "foreign" red cells — through a previous transfusion or a pregnancy. That process of forming them is called alloimmunization.7

Technically, the antibody screen relies on the indirect antiglobulin test (IAT), historically known as the indirect Coombs test: your plasma is mixed with reagent "screening" red cells carrying the major antigens, then an antihuman globulin reagent is added to reveal any agglutination — the sign that an antibody has bound.3 The antibodies most often sought target clinically important antigens: D, c, E, C, e (Rh system), K (Kell), Fya/Fyb (Duffy), Jka/Jkb (Kidd), S/s, and others.1

The antibody screen is not a blood type. It does not determine your ABO/Rh group — it complements it. Your blood type says which antigens you carry; the antibody screen says whether you've made antibodies against antigens you lack. In the U.S., the two are usually ordered together as the "type and screen" before a possible transfusion, and in early pregnancy.

Why the test is done

The antibody screen answers two situations where clinicians must be sure your antibodies won't destroy red blood cells:46

  • Before a transfusion (or before surgery that might need one). If you carry an irregular antibody, transfusing blood that has the matching antigen could trigger a hemolytic transfusion reaction. The screen lets the lab select compatible, antigen-negative units.1
  • During pregnancy. The screen detects possible maternal alloimmunization, especially anti-D in an Rh-negative woman. A maternal antibody can cross the placenta and attack the red cells of a fetus that carries the antigen — causing hemolytic disease of the fetus and newborn (HDFN).78

In the U.S., an antibody screen is standard in early pregnancy (often repeated around 28 weeks in Rh-negative women, before anti-D) and as part of pre-transfusion testing.42 It may also be ordered before certain scheduled surgeries.

Do you need to fast?

No. The antibody screen requires no fasting: it measures antibodies, which food does not change. You can eat and drink normally before the draw. Do tell your clinician about any recent transfusion, a current pregnancy, and your medications, since some drugs can interfere with the test and this information guides interpretation. For the general rules, see do you need to fast for a blood test?.6

Normal ranges: understanding "negative" and "positive"

The antibody screen is not reported as a number like glucose: it's a qualitative result — negative or positive — and, when positive, it's followed by antibody identification and a titer. Here's how to read a report:

Antibody screen resultWhat it means
NegativeNo irregular antibody detected. This is the most common result. Transfusion is simpler; reassuring in pregnancy (rechecked on schedule).
PositiveAt least one irregular antibody detected → precise identification (anti-D, -c, -E, -K…) and a titer are performed.

When the screen is positive, the lab goes further:14

  • Identification — which antibody? Some are clinically significant (anti-D, -c, -E, -K, -Fya, -Jka…) and require precautions; others have no usual consequence.
  • Titer — the highest dilution at which the antibody is still detectable (for example 1:8, 1:16, 1:32). In pregnancy, the trend matters: a rising titer prompts closer fetal monitoring. Critical thresholds vary by antibody and guideline (commonly around 1:16 for anti-D, and often lower for anti-K) and are interpreted by the medical team.8

Good to know: methods and thresholds vary by laboratory and blood bank. Only your clinician (or the obstetric/transfusion team) can interpret the result in your context. A negative screen may need to be repeated — for instance if it's more than a few days old before a transfusion, or at set points in pregnancy.6

Understanding your results

A positive antibody screen: what it means

A positive antibody screen means your body has made an antibody against a red-cell antigen you don't carry. That is not a disease — it's safety information. In practice:14

  • For transfusion: you'll receive crossmatch-compatible, antigen-negative blood (units lacking the antigen your antibody targets) to prevent a hemolytic reaction. This takes a little longer to prepare, which is why the screen is done ahead of time.
  • In pregnancy: an anti-D, anti-c, anti-E, or anti-K antibody can put the fetus at risk of HDFN if it carries the matching antigen. Monitoring is arranged (repeat titers, Doppler ultrasound) and, when needed, specialist care up to intrauterine transfusion.98

Anti-D remains the antibody of greatest concern, but after it, anti-K (Kell), anti-c, and anti-E are the most likely to cause fetal disease — which is why the screen looks for them routinely.9 See also our guides to the Rh factor and blood type and pregnancy.

A negative antibody screen: should you worry?

No — a negative screen is the expected, reassuring result: no irregular antibody is detectable. For a transfusion, it simplifies finding compatible blood. In pregnancy, it rules out alloimmunization as of the test date. One caveat: "negative today" doesn't mean "negative forever." Sensitization can develop later (after bleeding, a transfusion, or delivery), which is why screens are repeated on the schedule your clinician sets.64

Antibody screen, Rh factor, and anti-D: the connection

The antibody screen and the Rh factor work together. In an Rh-negative woman, the goal is to prevent her from forming anti-D against an Rh-positive fetus. The strategy combines:710

  • an antibody screen to confirm there's no anti-D (or other antibody);
  • Rh immune globulin (RhoGAM) for a non-immunized Rh-negative woman, which "mops up" fetal red cells before she can be sensitized.

Done properly, this prevents alloimmunization in about 99% of cases, cutting Rh sensitization from roughly 13–17% of at-risk pregnancies to under 1%.1112 A myth to drop: a positive screen is not a "couple incompatibility" or a sign of poor health — it's simply a factor to fold into care.

What affects your antibody screen

Several things change an antibody screen or how it's read:61

  • prior transfusion or pregnancy — the main reasons irregular antibodies appear (alloimmunization);
  • timing — a screen has limited validity (often a few days) before a transfusion, because an antibody can appear in between;
  • certain medications — some treatments cause lab interference; for example, anti-CD38 immunotherapy (such as daratumumab, used in hematology) can make the screen falsely positive and requires special techniques;3
  • antigen variants (weak D, partial D) — these can complicate interpretation and sometimes prompt genotyping;13
  • the laboratory and method used (gel column, solid phase…), which shift thresholds.

Always mention your transfusion history, any pregnancy, and your medications — they change how the result is read.

Recent research

According to recent PubMed-indexed publications:

  • Noninvasive fetal RHD genotyping. The fetal Rh type can now be determined from a simple maternal blood draw (cell-free fetal DNA). European screening programs show ≥99.9% sensitivity and let clinicians avoid unnecessary anti-D in 97–99% of women carrying an Rh-negative fetus, while targeting those who need it.1013
  • Extending genomics to non-D antibodies. Blood group genotyping and noninvasive fetal typing are expanding to anti-K, anti-c, and anti-E, to better gauge HDFN risk when a maternal screen is positive.9
  • A preventable disease still present worldwide. Globally, a large share of women who need it do not receive anti-D because of limited access — so HDFN remains too common. The antibody screen plus prophylaxis remain the pillars of prevention.11
  • Modern care for severe cases. Recent reviews describe advances in antenatal management (Doppler ultrasound, intrauterine transfusion) that improve outcomes for affected fetuses.8

These findings concern prevention and monitoring; management is always decided by your physician, obstetric team, and transfusion service.

Get your antibody screen interpreted by AI DiagMe

An antibody screen is never read alone: its meaning depends on your blood type, your Rh factor, the setting (transfusion, pregnancy), and — when positive — the identified antibody and its titer. That cross-reading is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

What is an antibody screen (indirect Coombs) test?
It's a blood test that looks for antibodies against red blood cells outside the ABO system (anti-D, -c, -E, -K, -Fya, -Jka…). It uses the indirect antiglobulin test and is used mainly before a transfusion and during pregnancy.
What does a negative antibody screen mean?
That no irregular antibody was detected — the expected, reassuring result. It makes transfusion simpler and rules out alloimmunization as of the test date. The screen may be repeated later depending on the situation.
What does a positive antibody screen mean?
That your blood contains an irregular antibody, which is then identified and titered. It's not a disease — it's safety information. For a transfusion, antigen-negative compatible blood is chosen; in pregnancy, appropriate monitoring is arranged.
Is a positive antibody screen dangerous?
By itself, no — it's a safety flag. The risk depends on the antibody identified and the context (an upcoming transfusion, a fetus carrying the antigen). The medical team tailors care accordingly.
Do I need to fast for an antibody screen?
No. No fasting is required. Just mention any recent transfusion, a pregnancy, and your medications.
Is the antibody screen the same as blood typing?
No. Typing (ABO, Rh) says which antigens you carry; the antibody screen says whether you've made antibodies against antigens you lack. The screen complements typing — the two together are the "type and screen."
Why is the antibody screen repeated during pregnancy?
Because sensitization can develop during pregnancy (bleeding, an invasive procedure, delivery). Repeating the screen at set points helps catch it early and act. The schedule depends on your Rh factor and situation.4
Does a positive screen mean I'm incompatible with my partner?
No. The screen doesn't measure "couple compatibility." It detects antibodies you have made. In pregnancy, what matters is whether the fetus carries the targeted antigen — hence the value of fetal genotyping.

Bottom line

The antibody screen — the indirect Coombs test — looks for red-cell antibodies outside ABO using the indirect antiglobulin test. Its result is negative (reassuring, no antibody) or positive (antibody identified and titered). It's essential before a transfusion (to choose compatible blood) and during pregnancy (to detect alloimmunization, especially anti-D, and prevent hemolytic disease of the newborn). A positive result is not a disease — it's safety information. No fasting needed. No value is read alone: it's your whole profile — blood type, Rh factor, the transfusion or pregnancy context — that counts, which is what AI DiagMe provides, alongside your physician.

Sources

Official U.S. sources and peer-reviewed publications (PubMed) used for this guide:

Footnotes

  1. Thornton NM, Grimsley SP. Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems. Immunohematology, 2019. PubMed ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  2. AABB (Association for the Advancement of Blood & Biotherapies) — Standards for pretransfusion testing: type and screen, antibody detection. aabb.org ↩ ↩2

  3. Sanders DR. Comparison of solid-phase red cell adherence and microcolumn agglutination technology using untreated and enzyme-treated red blood cells (antibody screen by indirect antiglobulin test). Immunohematology, 2023. PubMed · DOI ↩ ↩2 ↩3

  4. American College of Obstetricians and Gynecologists (ACOG) — Prevention of Rh D Alloimmunization and The Rh Factor: How It Can Affect Your Pregnancy. acog.org ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  5. MedlinePlus (U.S. National Library of Medicine, NIH) — Rh incompatibility and Antibody screen. medlineplus.gov ↩

  6. Testing.com — RBC Antibody Screen. testing.com ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  7. Ramsey G. The Rh blood group system: RHD update. Immunohematology, 2025. PubMed · DOI ↩ ↩2 ↩3

  8. de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth, 2023. PubMed · DOI ↩ ↩2 ↩3 ↩4

  9. Hyland CA, O'Brien H, Flower RL, Gardener GJ. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation. Transfus Apher Sci, 2020. PubMed · DOI ↩ ↩2 ↩3

  10. Clausen FB. Antenatal screening to guide antenatal anti-D immunoprophylaxis in non-immunized D− pregnant women. Immunohematology, 2024. PubMed · DOI ↩ ↩2

  11. Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality. PLoS One, 2020. PubMed · DOI ↩ ↩2

  12. Schwalb AM, Federspiel JJ, Dotters-Katz S, Kuller JA, Sugrue RP. Rhesus D Prophylaxis: When and Why We Give Rhesus D Immunoglobulin. Obstet Gynecol Surv, 2025. PubMed · DOI ↩

  13. Duan H, Li J, Jiang Z, Shi X, Hu Y. Noninvasive screening of fetal RHD genotype in pregnant women with serologic RhD-negative phenotype. Transfusion, 2023. PubMed · DOI ↩ ↩2

Medical disclaimer. This article is provided for informational and educational purposes only; it is not medical advice and does not replace a consultation. Reference ranges vary by laboratory and method: only your physician can interpret your results in your specific context.